Research in heart and lung diseases
The Clinical Trial Unit operates as an integral part of the Heart and Lung Center. The unit studies the treatment of heart and lung diseases. We conduct research on new experimental drugs as well as basic research that provides answers to questions about the origin and evolution of the diseases. The research is related to international collaborations, the pharmaceutical industry, or the researchers’ own observations.
The Clinical Trial Unit was established at the beginning of 2022. The unit’s goal is to provide better care for patients with heart and lung diseases. The Clinical Trial Unit connects and serves patients, the staff treating them, researchers, and the innovative industry. The Clinical Trial Unit currently has one research coordinator and three research nurses, as well as several researchers. The number of studies is growing rapidly.
Research patients are recruited for studies from the outpatient clinics in Meilahti Hospital and the Biobank, as well as through newspaper advertisements, depending on the research setting.
The Heart and Lung Center is responsible for the operations of the Clinical Trial Unit, and the staff is managed by the Director of Research and Education. The research coordinator is responsible for the coordination of the research.
Our research
In cooperation
Helsinki Biobank (opens in new window, links to another website)
In our research, we utilize samples and data resources stored in the biobank. Read more about biobank operations on the website of Helsinki Biobank. At the same time, you can give your voluntary biobank consent and give permission to deposit your sample in the biobank.
Research Programs Unit of the Faculty of Medicine (opens in new window, links to another website)
The Research Programs Unit (RPU) of the Faculty of Medicine consolidates demonstrated research excellence, with focused research programs addressing the greatest challenges in human health.
Southern Finland Regional Cancer Center FICAN South (opens in new window, links to another website)
The Southern Finland Regional Cancer Center FICAN South promotes cancer research in Southern Finland, and coordinates the diagnosis and treatment of cancer.
iCAN – Digital Precision Cancer Medicine (opens in new window, links to another website)
The iCAN research project aims to improve the treatment of cancer patients and support the development of new innovations stemming from high-quality cancer research.
THL Biobank (opens in new window, links to another website)
The THL Biobank promotes research into health and wellbeing.
E3 Pandemic Response Enterprise Solutions (opens in new window, links to another website)
The E3 Excellence in Pandemic Response and Enterprise Solutions project uses science and technology to create effective countermeasures to prevent the spread of new infectious diseases.
European Reference Networks – ERN (opens in new window, links to another website)
The members of the European Reference Networks consult other experts in the network and share information to support diagnostics and treatment planning.
European Reference Networks – ERN GUARD-Heart (opens in new window, links to another website)
ERN GUARD-Heart is a heart disease reference network that aims to facilitate access to diagnosis and treatment of rare and complex diseases of the heart in adult and pediatric patients across the European Union.
European Reference Networks – ERN LUNG (opens in new window, links to another website)
ERN-LUNG provides help and support for people with rare lung conditions.
Clinical Trial Unit for heart and lung diseases
The Clinical Trial Unit operates as an integral part of the Heart and Lung Center. We cooperate with pharmaceutical companies and European research centers.
